PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Human Evolutionary Biology, Harvard University, Cambridge, MA, USA. Electronic address: amarsarkar@g.harvard.edu.\', \'Tandy Court, Spitalfields, Dublin 8, D08 RP20, Ireland.\', \'Department of Ecology and Evolutionary Biology, Cornell University, Ithaca, NY, USA.\', \'W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.\', \'Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA.\', \'Wellcome Centre for Human Neuroimaging, University College London, London, UK.\', \'Department of Human Evolutionary Biology, Harvard University, Cambridge, MA, USA. Electronic address: carmody@fas.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1471-4914(21)00257-410.1016/j.molmed.2021.09.009
?:doi
?:hasPublicationType
?:journal
  • Trends in molecular medicine
is ?:pmid of
?:pmid
?:pmid
  • 34756546
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.876
?:rankingScore_hIndex
  • 153
?:title
  • The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all